Chronic Obstructive Pulmonary Disease with Type 2 Inflammation: Dupilumab Phase 3 BOREAS/NOTUS Study Results Event Type: Webinars Date: Tuesday, Oct. 1, 2024 | 2–3pm ET Register Link
